90 related articles for article (PubMed ID: 16445896)
21. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells.
Riond J; Elhmouzi J; Hudrisier D; Gairin JE
Scand J Immunol; 2007 Oct; 66(4):441-50. PubMed ID: 17850589
[TBL] [Abstract][Full Text] [Related]
22. Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.
Fraser JM; Janicki CN; Raveney BJ; Morgan DJ
Immunology; 2006 Sep; 119(1):126-33. PubMed ID: 16796693
[TBL] [Abstract][Full Text] [Related]
23. Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.
Chen X; Yan Y; Lu S; Weng X; Liang Z; Li J; Zhong M; Tang J; Xiao W; Sun W; Shen G; Wu X
Hum Immunol; 2009 Feb; 70(2):79-84. PubMed ID: 19100802
[TBL] [Abstract][Full Text] [Related]
24. Mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2-dependent pathways are essential for CD8+ T cell-mediated airway hyperresponsiveness and inflammation.
Ohnishi H; Takeda K; Domenico J; Lucas JJ; Miyahara N; Swasey CH; Dakhama A; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):249-57. PubMed ID: 19130938
[TBL] [Abstract][Full Text] [Related]
25. Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo.
Fernandez MA; Evans IA; Hassan EH; Carbone FR; Jones CA
Eur J Immunol; 2008 Jan; 38(1):102-13. PubMed ID: 18081035
[TBL] [Abstract][Full Text] [Related]
26. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
Rolle CE; Carrio R; Malek TR
Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
[TBL] [Abstract][Full Text] [Related]
27. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
28. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
29. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
[TBL] [Abstract][Full Text] [Related]
30. The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis.
Kennedy PT; Gehring AJ; Nowbath A; Selden C; Quaglia A; Dhillon A; Dusheiko G; Bertoletti A
J Viral Hepat; 2008 Dec; 15(12):901-9. PubMed ID: 19087227
[TBL] [Abstract][Full Text] [Related]
31. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
32. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
[TBL] [Abstract][Full Text] [Related]
33. Redox modulation inhibits CD8 T cell effector function.
Sklavos MM; Tse HM; Piganelli JD
Free Radic Biol Med; 2008 Nov; 45(10):1477-86. PubMed ID: 18805480
[TBL] [Abstract][Full Text] [Related]
34. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis.
Mehal WZ; Azzaroli F; Crispe IN
J Immunol; 2001 Jul; 167(2):667-73. PubMed ID: 11441069
[TBL] [Abstract][Full Text] [Related]
35. Peptide-induced deletion of CD8 T cells in vivo occurs via apoptosis in situ.
Koniaras C; Bennett SR; Carbone FR; Heath WR; Lew AM
Int Immunol; 1997 Oct; 9(10):1601-5. PubMed ID: 9352366
[TBL] [Abstract][Full Text] [Related]
36. Local intrahepatic CD8+ T cell activation by a non-self-antigen results in full functional differentiation.
Wuensch SA; Pierce RH; Crispe IN
J Immunol; 2006 Aug; 177(3):1689-97. PubMed ID: 16849478
[TBL] [Abstract][Full Text] [Related]
37. Naïve CD8 T cell activation by liver bone marrow-derived cells leads to a "neglected" IL-2low Bimhigh phenotype, poor CTL function and cell death.
Holz LE; Benseler V; Vo M; McGuffog C; Van Rooijen N; McCaughan GW; Bowen DG; Bertolino P
J Hepatol; 2012 Oct; 57(4):830-6. PubMed ID: 22659099
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells.
Bowen DG; Warren A; Davis T; Hoffmann MW; McCaughan GW; Fazekas de St Groth B; Bertolino P
Gastroenterology; 2002 Oct; 123(4):1252-64. PubMed ID: 12360486
[TBL] [Abstract][Full Text] [Related]
39. Passive and active mechanisms trap activated CD8+ T cells in the liver.
John B; Crispe IN
J Immunol; 2004 May; 172(9):5222-9. PubMed ID: 15100260
[TBL] [Abstract][Full Text] [Related]
40. Effective intrahepatic CD8+ T-cell immune responses are induced by low but not high numbers of antigen-expressing hepatocytes.
Ochel A; Cebula M; Riehn M; Hillebrand U; Lipps C; Schirmbeck R; Hauser H; Wirth D
Cell Mol Immunol; 2016 Nov; 13(6):805-815. PubMed ID: 26412123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
